Latest / Annapolis News Today | 2 Min News | The Daily News Now!
Prescription Rejections Surge Amid Weight Loss Drug Costs | Annapolis News
One in three brand-name prescriptions are now initially denied by insurers, a 67% jump since 2018, with nearly half never filled—driven largely by skyrocketing demand for weight-loss drugs like Ozempic and Wegovy, which insurers restrict due to cost. A Johns Hopkins study of 2 million prescriptions reveals insurers are slashing coverage, especially for GLP-1 drugs, which face an 85% rejection rate. As states and insurers impose caps, experts urge drugmakers to negotiate lower prices to restore access and curb costs. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.